These findings highlight the critical role of HGF from CAFs in mediating chemoresistance in A549 lung cancer cells through the Met/PI3K/AKT pathway, suggesting that targeting this axis could enhance the efficacy of paclitaxel therapy. The gene discussed is PIK3CA; the disease is lung carcinoma.